Total Payments
$7,450
2024 Payments
$1,035
Companies
34
Transactions
626
Medicare Patients
992
Medicare Billing
$71,766
Payment Breakdown by Category
Food & Beverage$7,281 (97.7%)
Education$168.72 (2.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,281 | 621 | 97.7% |
| Education | $168.72 | 5 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,028 | 309 | $0 (2024) |
| ABBVIE INC. | $1,389 | 98 | $0 (2024) |
| NuVasive, Inc. | $485.67 | 3 | $0 (2023) |
| PFIZER INC. | $461.75 | 34 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $452.23 | 30 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $434.81 | 24 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $254.18 | 12 | $0 (2024) |
| Braintree Laboratories, Inc. | $241.70 | 13 | $0 (2024) |
| Celgene Corporation | $187.76 | 13 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $119.28 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,035 | 49 | Janssen Biotech, Inc. ($290.90) |
| 2023 | $1,440 | 58 | NuVasive, Inc. ($485.67) |
| 2022 | $1,092 | 75 | ABBVIE INC. ($300.34) |
| 2021 | $848.81 | 98 | Janssen Biotech, Inc. ($400.02) |
| 2020 | $389.43 | 48 | Janssen Biotech, Inc. ($173.85) |
| 2019 | $1,074 | 124 | Janssen Biotech, Inc. ($353.55) |
| 2018 | $862.60 | 97 | Janssen Biotech, Inc. ($268.54) |
| 2017 | $706.79 | 77 | AbbVie, Inc. ($136.98) |
All Payment Transactions
626 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.36 | General |
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.04 | General |
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 10/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.44 | General |
| 09/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: GI COLON PREP | ||||||
| 09/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Oncology | ||||||
| 08/30/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $2.22 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/01/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 276 | 312 | $38,034 | $21,273 |
| 2022 | 7 | 250 | 273 | $30,965 | $19,148 |
| 2021 | 7 | 254 | 281 | $30,591 | $17,453 |
| 2020 | 5 | 212 | 243 | $24,608 | $13,892 |
Total Patients
992
Total Services
1,109
Medicare Billing
$71,766
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 42 | 42 | $13,899 | $8,424 | 60.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 42 | 47 | $7,709 | $4,163 | 54.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 15 | 15 | $4,075 | $2,604 | 63.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 33 | $4,960 | $2,391 | 48.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $2,755 | $1,624 | 58.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $1,453 | $835.10 | 57.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2023 | 14 | 15 | $1,055 | $660.22 | 62.6% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 114 | 135 | $2,128 | $570.92 | 26.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 29 | 29 | $8,240 | $5,502 | 66.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 38 | 42 | $6,435 | $3,524 | 54.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 14 | 14 | $3,482 | $2,505 | 71.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $3,725 | $2,329 | 62.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 27 | $4,060 | $2,291 | 56.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $2,312 | $1,743 | 75.4% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2022 | 15 | 16 | $1,061 | $764.26 | 72.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 100 | 113 | $1,650 | $489.12 | 29.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 38 | 39 | $11,634 | $7,574 | 65.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 42 | 47 | $7,193 | $4,532 | 63.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 14 | 14 | $2,953 | $2,044 | 69.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 22 | $2,254 | $1,291 | 57.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 16 | 17 | $1,615 | $791.12 | 49.0% |
| 43450 | Dilation of esophagus unguided | Facility | 2021 | 17 | 23 | $3,030 | $685.74 | 22.6% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2021 | 107 | 119 | $1,912 | $535.00 | 28.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 38 | 40 | $10,655 | $7,409 | 69.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 37 | 38 | $5,514 | $3,146 | 57.1% |
About Dr. Michael Kader, MD
Dr. Michael Kader, MD is a Gastroenterology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306854682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Kader, MD has received a total of $7,450 in payments from pharmaceutical and medical device companies, with $1,035 received in 2024. These payments were reported across 626 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($7,281).
As a Medicare-enrolled provider, Kader has provided services to 992 Medicare beneficiaries, totaling 1,109 services with total Medicare billing of $71,766. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Rochester, NY
- Active Since 08/03/2006
- Last Updated 12/08/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1306854682
Products in Payments
- STELARA (Biological) $1,895
- XELJANZ (Drug) $384.07
- RINVOQ (Biological) $319.00
- XIFAXAN (Drug) $268.29
- Humira (Biological) $231.12
- SKYRIZI (Biological) $198.71
- REBYOTA (Biological) $191.34
- ZEPOSIA (Drug) $187.76
- ENTYVIO (Biological) $186.88
- LINZESS (Drug) $185.33
- RELINE (Device) $172.58
- Creon (Drug) $127.28
- DUPIXENT (Biological) $122.40
- Cimzia (Drug) $118.88
- IBSRELA (Drug) $114.64
- SUTAB (Drug) $112.69
- MAVYRET (Drug) $110.93
- HUMIRA (Biological) $107.47
- TREMFYA (Drug) $101.81
- RELISTOR (Drug) $91.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Rochester
Edward Loftus, M.d, M.D
Gastroenterology — Payments: $379,661
Gastroenterology $379,661
Christopher Gostout, M.d, M.D
Gastroenterology — Payments: $317,848
Gastroenterology $317,848
Vivek Kaul, Md, MD
Gastroenterology — Payments: $307,068
Gastroenterology $307,068
Todd Baron, M.d, M.D
Gastroenterology — Payments: $296,029
Gastroenterology $296,029
Russell Wiesner, M.d, M.D
Gastroenterology — Payments: $231,350
Gastroenterology $231,350
Joseph Murray, M.d, M.D
Gastroenterology — Payments: $200,483
Gastroenterology $200,483